Abstract:Background: The RIP1-RIP3-MLKL-mediated cell death pathway is associated with progression of non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). Previous work identified a critical role for MLKL, the key effector regulating necroptosis, but not RIP3, in mediating high fat diet-induced liver injury in mice. RIP1 and RIP3 have active N-terminus kinase domains essential for activation of MLKL and subsequent necroptosis. However, little is known regarding domain-specific roles of RIP1/RIP3 kinase in liver diseases. Here, we hypothesized that RIP1/RIP3 kinase activity are required for the development of high fat diet-induced liver injury. Methods: Rip1K45A/K45A and Rip3K51A/K51A kinase-dead mice on a C57BL/6J background and their littermate controls (WT) were allowed free access to a diet high in fat, fructose and cholesterol (FFC diet) or chow diet. Results: Both Rip1K45A/K45A and Rip3K51A/K51A mice were protected against FFC diet-induced steatosis, hepatocyte injury and expression of hepatic inflammatory cytokines and chemokines. FFC diet increased phosphorylation and oligomerization of MLKL and hepatocyte death in livers of WT, but not in Rip3K51A/K51A, mice. Consistent with in vivo data, RIP3 kinase deficiency in primary hepatocytes prevented palmitic acid-induced translocation of MLKL to the cell surface and cytotoxicity. Additionally, loss of Rip1 or Rip3 kinase suppressed FFC diet-mediated formation of crown-like structures (indicators of dead adipocytes) and expression of mRNA for inflammatory response genes in epididymal adipose tissue. Moreover, FFC diet increased expression of multiple adipokines, including leptin and plasminogen activator inhibitor 1, in WT mice, which was abrogated by Rip3 kinase deficiency. Discussion: The current data indicate that both RIP1 and RIP3 kinase activity contribute to FFC diet-induced liver injury. This effect of RIP1 and RIP3 kinase deficiency on injury is consistent with the protection of Mlkl-/- mice from high fat diet-induced liver injury, but not the reported lack of protection in Rip3-/- mice. Taken together with previous reports, our data suggest that other domains of RIP3 likely counteract the effect of RIP3 kinase in response to high fat diets.

Differential role of MLKL in alcohol-associated and non–alcohol-associated fatty liver diseases in mice and humans

Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis

The Role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.

Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice

NLRP6 Inflammasome Modulates Disease Progression in a Chronic-Plus-Binge Mouse Model of Alcoholic Liver Disease

Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in mice

Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High Fat, High Fructose, High Cholesterol Diet Mouse Model

Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model

Receptor-Interacting Serine/Threonine-Protein Kinase 3 (Ripk3)-Mixed Lineage Kinase Domain-Like Protein (Mlkl)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers

MLKL deficiency attenuated hepatocyte oxidative DNA damage by activating mitophagy to suppress macrophage cGAS-STING signaling during liver ischemia and reperfusion injury

Alcohol-induced Liver Injury is Modulated by Nlrp3 and Nlrc4 Inflammasomes in Mice.

Roles of necroptosis in alcoholic liver disease and hepatic pathogenesis

LncRNA 1700020i14rik Promotes AKR1B10 Expression and Activates Erk Pathway to Induce Hepatocyte Damage in Alcoholic Hepatitis

Phospholipase D2 Drives Cellular Lipotoxicity and Tissue Inflammation in Alcohol-Associated Liver Disease

Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation

Role of gp91phox in hepatic macrophage programming and alcoholic liver disease.

Long Non-Coding RNA CRNDE As Potential Biomarkers Facilitate Inflammation and Apoptosis in Alcoholic Liver Disease.

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease